Clinical relevance of positively determined myositis antibodies in rheumatology: a retrospective monocentric analysis
Authors' conclusion
In our cohort, we were able to show that a relevant proportion of patients with positive myositis antibodies did not have idiopathic inflammatory myopathies or inflammatory rheumatic diseases.
Study context
- Population
- Patients with positive myositis autoantibodies, Department of Rheumatology, Krankenhaus Porz am Rhein, Cologne, Germany, July 2019 to May 2022238 positive autoantibodies
- Participants
- 209 patients
- Outcome
- Diagnoses in patients with positive myositis autoantibodies
Methodological detailsmonocentric, 71,597 laboratory values for myositis antibodies obtained
- Monocentric
- 71,597 laboratory values for myositis antibodies obtained
Main finding
As reported in the abstract
IIM diagnosed
37
18%
Inflammatory rheumatic diseases other than IIM
90
43%
No inflammatory rheumatic disease
82
39%
Observational data: associations, not effects.
Original publication
Clinical relevance of positively determined myositis antibodies in rheumatology: a retrospective monocentric analysis. Arthritis Res Ther. Published 16 July 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →